Search

Appendiceal neoplasms (ANs) are a diverse group of pathologies that range from benign to malignant with widely varying prognoses. This article serves as an overview of the practical approach to evaluating and managing a patient with AN by reviewing the current literature and guidelines to provide a framework for the management of these nuanced pathologies., (© 2023 The Authors. Journal of Surgical Oncology published by Wiley Periodicals LLC.)

Purpose of Review: The Covid-19 pandemic forced residency programs to drastically change their interview processes and adopt virtual interviewing for the 2020-2021 match cycle., Recent Findings: While virtual interviewing decreased cost and increased convenience for applicants and programs involved in the match, it also introduced several potential disadvantages. Maximizing technological capabilities was an area of utmost concern at the start of the interview cycle, and multiple medical education organizations quickly recommended ways to move to virtual process, and to prevent and troubleshoot technical problems. However, other issues were less straightforward, such as how to address new sources of bias introduced by virtual interviewing, and how to ensure that programs and applicants could make informed decisions about their rank lists after only limited virtual interactions. Additionally, the increased convenience of interviewing raised concerns that students would accept more interviews, disrupting the established calculus programs used to determine how many interviews to offer per spot available., Summary: In this review, we examine the benefits and disadvantages of virtual interviewing, review recommendations from the current literature on how to improve the process, and discuss what we learned from our own experience at an academic general surgery residency program over the course of this unprecedented interview season., Competing Interests: Conflict of interestThere are no conflicts of interest., (© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.)

Objective: To determine the effectiveness of competition on education conference attendance rate with a secondary goal of increased performance on in-service examination performance within a single academic general surgery residency., Design: By using a competition-based model of learning, we aimed to increase the overall resident attendance to weekly education conference as well as performance on in-service examination. Residents were given weekly reading assignments which were supplemented with lectures from faculty with expert knowledge of a given topic on a weekly basis. The ability of the surgical resident to apply this knowledge in a board-style exam was then tested on a weekly by administering a 10-question quiz., Setting: The program was implemented at Robert Wood Johnson Medical School, an academic surgical residency program., Results: The competition-based model of learning had improved conference attendance rates from 52% to 90% Overall quiz participation rates were 90.3% (SEM = 6.32%). Of the 5 distinct postgraduate levels performing on the weekly quizzes, the postgraduate year (PGY) 3 class performed best with the highest scores through 8 weeks. The next highest scoring class was the PGY 4 class. Overall average scores were 76% (standard deviation 10%). American Board of Surgery In-Training Examination scores did not significantly change between the observed years. Overall the average percentile for 2016 American Board of Surgery In-Training Examination was 55.3 compared to 2017's 47.4 (p = 0.0906)., Conclusions: After adding competition to our weekly education conference, we were able to improve our overall education conference attendance. Although this change did not have any objective changes measured on in-service examination results, we feel the increase in attendance and participation within education conference can only serve to benefit the surgical trainee. The establishment of this program has increased resident academic expectations, and a formalized guest-attending lecture schedule only drives conference participation higher. The establishment of weekly quizzes for and by residents allows the student to be more involved in their own education, and that of their peers., (Published by Elsevier Inc.)

Prior studies examining the risk of second primary malignancy (SPM) after a first primary cancer generally have used large datasets such as the Surveillance, Epidemiology, and End Results (SEER) registry and excluded survivors of previous primaries and developers of synchronous primaries. The goal of this study was to provide a more complete representation of multiple cancer risk in squamous cell carcinoma of the anus (SCCA) patients. A single-institution retrospective study of 46 patients treated definitively for SCCA between January 2006 and July 2017 was conducted. Of the 46 patients, 18 (39%) had either a primary malignancy before SCCA (n=9) or SPM after an index SCCA (n=9). Six patients had ≥3 total malignancies. In our cohort, patients without SPMs tended to die from SCCA recurrence, while patients with SPMs were more likely to die from their SPM than from SCCA. Our study suggests that patients with SCCA are often either survivors of previous cancers or develop later malignancies. Several risk factors may play a role including HPV infection, HPV-related or treatment-related immunosuppression, somatic mutations due to chemotherapy, and genetic factors. Patients with SCCA require lifelong surveillance given their elevated risk of malignancy. Future work should focus on identifying genomic or immunologic factors that may predispose SCCA patients to develop multiple primary malignancies., Competing Interests: Conflicts of Interest: Salma K. Jabbour has received research grants from Merck and Nestle. The other authors have no conflicts of interest to declare.

Colorectal cancer incidence and death rates have been declining over the past 10 years. However, it remains the second leading cause of death in men ages 60-79 and the third leading cause of death in men over 80 and in women over 60 years old. However, there is little data specific to the treatment of the elder patient, since few of these patients are included in trials. With the advent of improved therapies, there are many alternative options available. Still, no definitive consensus or guidelines have been defined for this particular patient population. The goal of this study is to review the literature on the management of rectal cancer in the elderly and to propose treatment algorithms to help the oncology team in treatment decision-making., Competing Interests: Conflicts of Interest: The authors have no conflicts of interest to declare.

Rectal cancer predominantly affects patients older than 70 years, with peak incidence at age 80 to 85 years. However, the standard treatment paradigm for rectal cancer oftentimes cannot be feasibly applied to these patients owing to frailty or comorbid conditions. There are currently little information and no treatment guidelines to help direct therapy for patients who are elderly and/or have significant comorbidities, because most are not included or specifically studied in clinical trials. More recently various alternative treatment options have been brought to light that may potentially be utilized in this group of patients. This critical review examines the available literature on alternative therapies for rectal cancer and proposes a treatment algorithm to help guide clinicians in treatment decision making for elderly and comorbid patients., (Copyright © 2017 Elsevier Inc. All rights reserved.)

Background: This study seeks to quantify and compare bone marrow tolerance during postoperative chemotherapy therapy between rectal cancer vs. colon cancer patients. During rectal cancer treatment, patients receive neoadjuvant chemoradiation (CRT) irradiation which can exacerbate the hematologic toxicity (HT) via incidental irradiation of the pelvic bone marrow (PBM) during myelosuppressive postoperative chemotherapy. In contrast, colon cancer patients receive the same postoperative myelosuppressive chemotherapy but do not routinely receive preoperative chemoradiation therapy. This comparison will help elucidate the lasting myelosuppressive effects of incidental pelvic bone marrow (PBM) irradiation on rectal cancer patients during neoadjuvant preoperative chemoradiation therapy., Methods: Rectal cancer patients treated with preoperative CRT followed by postoperative 5-Fluorouracil and oxaliplatin (OxF) chemotherapy (n=35) were compared to colon cancer patients who received only postoperative OxF chemotherapy (n=42). End points were ≥ grade 3 hematologic toxicity (HT3) or hematologic event (HE) defined as ≥ grade 2 HT and a dose reduction in OxF. Wilcoxon rank sum test tested continuous variables and Chi-squared test measured differences in categorical variables. HT3 and HE probability during postoperative chemotherapy was estimated with Kaplan-Meier curves and Cox regression analysis., Results: During OxF chemotherapy, 40.0% (n=14) of rectal cancer patients experienced HT3 compared to 26.1% (n=11) of colon cancer patients (P=0.4). HE was experienced by 48% (n=17) of rectal cancer patients compared to 36% (n=15) of colon cancer patients (P=0.36). Rectal cancer patients were likelier to experience HT3 on multivariable cox regression analysis, controlling for several clinical covariates, with a hazard ratio (HR) of 2.49, [(95% CI: 1.02-6.02), P=0.045] than colon cancer patients. While rectal cancer patients were more likely to experience HE than colon cancer patients on multivariable Cox regression analysis with a HR of 1.8 (95% CI: 0.95-3.75), this only trended in statistical significance, P=0.07., Conclusions: Rectal cancer patients are more likely than colon cancer patients to experience hematologic toxicities impacting the tolerance of standard of care chemotherapeutics during adjuvant therapy. Focused PBM sparing during radiation therapy for rectal cancer patients may improve tolerance of myelosuppressive chemotherapeutic agents delivered in the postoperative setting., Competing Interests: Conflicts of Interest: The authors have no conflicts of interest to declare.